LAWRENCE, Mass.--(BUSINESS WIRE)--Nexcelom Bioscience LLC, provider of innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced it continues to ...
Nexcelom Bioscience LLC, provider of innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced a major enhancement — the addition of ...
Expertise in Automated Cell Counting and Analysis In 2003, the founders of Nexcelom introduced the CP2, a convenient tool to assist with manual cell counting. According to Dr. Jean Qiu, founder and ...
Ampersand Capital Partners has sold Nexcelom Bioscience to PerkinElmer for $260 million. Based in Lawrence, Massachusetts, Nexcelom is a provider of automated cell counting solutions. WELLESLEY, Mass.
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing Nexcelom is a leading, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results